Celvapan

Influenza A/H1N1 vaccine (cell-derived) · Novartis Vaccines

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Celvapan, covering 2016-12-01 to 2016-12-21. Get the full timeline:

Most recent: EMA Withdrawn: Celvapan (whole virion influenza vaccine, inactivated containing antigen of strain A/California/07/2009 (H1N1)v) — Nanotherapeutics Bohumil, s.r.o.

See pricing